The study, led by researchers at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine in Hangzhou, China, and published in Frontiers in Cardiovascular Medicine, drew on 423,162 UK Biobank participants who had no cardiovascular disease, no conduction disorder, and no pacemaker at baseline. The UK Biobank recruited more than 500,000 adults aged 40 to 69 across the United Kingdom between 2006 and 2010, collecting touchscreen questionnaires, nurse-led interviews, physical measurements, and biological samples, then linking participants to national hospital records, procedure records, and death registries over long-term follow-up. That infrastructure allowed the team to track who developed conduction problems over roughly sixteen years of average follow-up, with data extracted through 4 September 2025 as the analytical cutoff.

To measure frailty, the researchers used a modified version of the Fried frailty phenotype, a clinical framework that scores five components: unintentional weight loss, exhaustion, low physical activity, slow walking pace, and weak grip strength. Each component contributes one point, producing a score from zero to five. Participants scoring zero were classified as non-frail, those scoring one or two as prefrail, and those scoring three or higher as frail. In the final cohort, 246,284 participants, or 58.2 percent, were non-frail; 162,868, or 38.5 percent, were prefrail; and 14,010, or 3.3 percent, were frail. Anyone with pre-existing cardiovascular disease, conduction disorders, or pacemaker implantation was excluded, sharpening the focus on new, incident disease.

The results were striking in their consistency. Over follow-up, 18,067 participants developed a cardiac conduction disorder, 10,652 experienced the severe conduction outcome composite, and 5,710 developed a left bundle branch or fascicular block. Crude event rates climbed steadily across frailty categories: 3.6 percent of non-frail participants developed overall conduction disease, compared with 4.9 percent of prefrail and 8.6 percent of frail participants. Kaplan-Meier curves showed progressively lower event-free survival with increasing frailty for all three outcomes, with log-rank P values below 0.0001.

Statistical modeling sharpened the picture. In the fully adjusted Cox proportional hazards model, which accounted for age, sex, race, education, socioeconomic deprivation, smoking, alcohol consumption, hypertension, diabetes, dyslipidemia, body mass index, and kidney function, prefrail participants had a 23 percent higher risk of incident conduction disorder than non-frail participants, a hazard ratio of 1.23 with a 95 percent confidence interval of 1.19 to 1.27. Frail participants faced a 71 percent higher risk, a hazard ratio of 1.71 with a confidence interval of 1.60 to 1.83. Each one-point increase in the frailty score carried an adjusted hazard ratio of 1.19. Restricted cubic spline analysis confirmed a graded, essentially linear relationship, with no strong evidence of departure from linearity for overall conduction disease.

The secondary outcomes told a similar story. For the severe conduction composite, defined as the first occurrence of third-degree atrioventricular block or a pacemaker-related procedure, the fully adjusted hazard ratios were 1.13 for prefrail participants and 1.44 for frail participants. For left bundle branch or fascicular block, the corresponding figures were 1.24 and 1.61. Because pacemakers can be implanted for reasons other than advanced conduction block, such as sinus node dysfunction, the team also ran a sensitivity analysis restricted strictly to third-degree atrioventricular block; the adjusted hazard ratios of 1.20 for prefrailty and 1.57 for frailty indicated the association was not driven solely by pacemaker procedures.

Robustness checks reinforced the findings. When the researchers excluded events occurring in the first two years of follow-up to limit reverse causation, the possibility that pre-existing but undiagnosed illness causes both frailty and conduction disease, the hazard ratios for frail versus non-frail participants remained elevated at 1.68 for overall conduction disorder, 1.38 for the severe composite, and 1.59 for bundle branch or fascicular block. Analyses excluding participants who died during follow-up produced similar estimates, and a sensitivity analysis imposing a uniform administrative censoring date of 30 September 2021 yielded directionally consistent results, addressing concerns about variable record completeness in later data.

One of the most provocative findings emerged from exploratory subgroup analyses. Nominal evidence of interaction by age suggested that the relative association was stronger among participants younger than 65, where the frail versus non-frail hazard ratio reached 1.86, than among those 65 and older, where it was 1.49. The authors offer a plausible interpretation: frailty may convey more relative risk information when the background incidence of age-related conduction disease is lower, because age itself does less of the explanatory work. Interactions by sex and race were absent, and associations were present across all strata. The researchers are careful to note that these subgroup analyses involved multiple unadjusted comparisons and small numbers in some categories, so they should be treated as hypothesis-generating rather than confirmatory.

The study builds on, and closely aligns with, an earlier UK Biobank investigation that examined physical frailty and incident arrhythmias more broadly, treating conduction system disease as one of several secondary categories. That study reported an adjusted hazard ratio of 1.20 for prefrailty and 1.56 for frailty, with 1.15 per additional frailty component; the present analysis found 1.23, 1.71, and 1.19 for overall conduction disease. The convergence of the two studies under related but non-identical outcome definitions and model specifications suggests the association is reproducible rather than a statistical artifact. What the new work adds is a focused characterization: separate estimates for clinically distinct outcomes, including severe block requiring pacemaker intervention and left bundle branch or fascicular block.

Conceptually, the findings shift the conversation from individual risk factors, such as obesity or cardiovascular health metrics, toward an integrated functional phenotype. Frailty can be assessed with simple physical and questionnaire-based measures that require no specialized equipment, making it a pragmatic candidate for risk stratification in primary care. Yet the authors are emphatic about the limits of interpretation. This was an observational study, so causality cannot be established, and it remains unknown whether reversing frailty would reduce conduction disease risk. Frailty and covariates were measured only at baseline, changes in health status, medications, and diagnostic practices over the long follow-up were not captured, and outcomes were identified mainly from hospital records, meaning subclinical or outpatient-only abnormalities may have been missed. The modified Fried phenotype also relied partly on self-reported components, introducing potential misclassification, and UK Biobank participants are healthier and less diverse than the general population, which may restrict generalizability.

Even with those caveats, the message is compelling: the body’s overall physiological reserve, reflected in something as mundane as grip strength and walking speed, appears to carry information about the heart’s electrical health that chronological age and standard cardiometabolic measures do not fully capture. With 38.5 percent of middle-aged and older adults in the cohort already prefrail, and excess risk evident at that earliest stage, the findings suggest a large population in whom conduction vulnerability could be identified well before symptoms appear. The researchers call for external validation, longitudinal reassessment of frailty over time, and analyses that account for competing mortality before frailty assessment enters routine preventive cardiology. But the study marks a meaningful step toward prevention-oriented epidemiology of conduction disease, reframing the heart’s wiring as a target whose risks may be readable, years in advance, from the body as a whole.

Subject of Research: Association of physical frailty with incident cardiac conduction disorders in a large prospective UK Biobank cohort

Article Title: Association of physical frailty with cardiac conduction disorder events in the UK Biobank

Article References: Tang, Q., Lyv, J., Li, C., Wang, M., Fu, G., Wang, Y., & Yu, L. (2026). Association of physical frailty with cardiac conduction disorder events in the UK Biobank. Frontiers in Cardiovascular Medicine, 13, Article 1967667. https://doi.org/10.3389/fcvm.2026.1967667

Image Credits: AI Generated

DOI: 10.3389/fcvm.2026.1967667

Keywords: cardiac conduction disorder, physical frailty, UK Biobank, prefrailty, bundle branch block, atrioventricular block, pacemaker, Fried frailty phenotype, epidemiology, cardiovascular risk, hazard ratio, conduction system disease